From Concept to Medicine - A Comprehensive Drug Development Journey
19 Exenatide (S24E19)
· 21 min · Season 24 Episode 19
Show notes
In this episode of The Deep Dive, we explore the remarkable journey of exenatide, a diabetes medication that began in an unlikely place—Gila monster saliva. As the first GLP-1 receptor agonist approved for type 2 diabetes, exenatide paved the way for an entirely new class of blood sugar–lowering treatments. We trace its evolution from the twice-daily Byetta to the once-weekly Bydureon, highlighting the innovations in drug delivery—like microsphere formulations and prefilled pens—that made it more patient-friendly. Listeners will gain a clear understanding of how exenatide works in the body…
Website: rss.com
